These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15339861)

  • 1. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.
    Christians U; Gottschalk S; Miljus J; Hainz C; Benet LZ; Leibfritz D; Serkova N
    Br J Pharmacol; 2004 Oct; 143(3):388-96. PubMed ID: 15339861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism.
    Klawitter J; Gottschalk S; Hainz C; Leibfritz D; Christians U; Serkova NJ
    Chem Res Toxicol; 2010 Mar; 23(3):608-19. PubMed ID: 20148532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain.
    Serkova N; Jacobsen W; Niemann CU; Litt L; Benet LZ; Leibfritz D; Christians U
    Br J Pharmacol; 2001 Jul; 133(6):875-85. PubMed ID: 11454661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
    Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
    Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of cyclosporin a on the metabolism of perfused rat brain slices during normoxia and hypoxia.
    Serkova N; Donohoe P; Gottschalk S; Hainz C; Niemann CU; Bickler PE; Litt L; Benet LZ; Leibfritz D; Christians U
    J Cereb Blood Flow Metab; 2002 Mar; 22(3):342-52. PubMed ID: 11891440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.
    Gottschalk S; Cummins CL; Leibfritz D; Christians U; Benet LZ; Serkova NJ
    Neurotoxicology; 2011 Jan; 32(1):50-7. PubMed ID: 21075140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy.
    Serkova N; Litt L; James TL; Sadée W; Leibfritz D; Benet LZ; Christians U
    J Pharmacol Exp Ther; 1999 May; 289(2):800-6. PubMed ID: 10215655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.
    Niemann CU; Saeed M; Akbari H; Jacobsen W; Benet LZ; Christians U; Serkova N
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1123-8. PubMed ID: 12183671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F
    J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
    Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
    PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation.
    Venet F; Demaret J; Blaise BJ; Rouget C; Girardot T; Idealisoa E; Rimmelé T; Mallet F; Lepape A; Textoris J; Monneret G
    J Immunol; 2017 Sep; 199(5):1606-1615. PubMed ID: 28724580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats.
    Shing CM; Fassett RG; Brown L; Coombes JS
    Transpl Int; 2012 Mar; 25(3):337-46. PubMed ID: 22239125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus.
    Lamoureux F; Picard N; Boussera B; Sauvage FL; Marquet P
    Fundam Clin Pharmacol; 2012 Aug; 26(4):463-72. PubMed ID: 21631587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells.
    Jesus TT; Oliveira PF; Silva J; Barros A; Ferreira R; Sousa M; Cheng CY; Silva BM; Alves MG
    Fertil Steril; 2016 Mar; 105(3):825-833.e3. PubMed ID: 26698679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat.
    Serkova N; Klawitter J; Niemann CU
    Transpl Int; 2003 Oct; 16(10):748-55. PubMed ID: 12827232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mTOR inhibitor sirolimus suppresses renal, hepatic, and cardiac tissue cellular respiration.
    Albawardi A; Almarzooqi S; Saraswathiamma D; Abdul-Kader HM; Souid AK; Alfazari AS
    Int J Clin Exp Pathol; 2015; 8(3):2955-62. PubMed ID: 26045804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
    Wowro SJ; Schmitt KRL; Tong G; Berger F; Schubert S
    Int Immunopharmacol; 2016 Jan; 30():9-17. PubMed ID: 26613512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
    Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P
    Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.